S ince the initial use of bubbles for echocardiographic contrast, it has been a common clinical observation that these bubbles are disrupted in a sonographic field. It was recognized that the frequency and power of the ultrasound beam were key elements in the efficiency of this disruption, and it was concluded that bubble resonance, leading to cavitation, caused bubble destruction. The combination of ultrasound and microbubbles as a therapeutic modality was described in 1998, as an approach to in vivo arterial clot dissolution. 1 Subsequently, this combination has been investigated for delivery of bioactive molecules and has been shown to deliver plasmids with reporter constructs to a variety of target organs, usually with low efficiency. More recently, it has been observed that in the presence of microbubbles, even levels of ultrasound energy that would not be expected to produce cavitation can augment delivery of macromolecules. Thus, there may be 2 distinct processes of cell permeabilization occurring in the presence of ultrasound and microbubbles. High acoustic pressure leads to cavitation, causing the bubbles to implode, with substantial release of energy, driving lipid shell through the cell membrane. (This process has been called UTMD for ultrasound targeted microbubble destruction.) Lower acoustic pressure produces subcavitary oscillation and has been suggested to activate the cell membrane to allow for transfer of macromolecules. 2 In the article by Meijering et al in this issue of Circulation Research, this process of low energy permeabilization is called, somewhat confusingly, UMTD (for ultrasound and microbubble-targeted delivery). In addition to the direct relationship with the applied acoustic pressure, other variables that influence whether microbubbles will stably oscillate or cavitate include size, density, 3 and composition. 4 Considerable effort has been expended to optimize microbubble composition, ultrasound parameters, and experimental methods to enhance the transfer of genes or drugs into cells. These have primarily focused on relatively high acoustic energies with an assumed mechanism of cavitation and transient pore formation. By contrast, potential mechanisms for the noncavitational process relate to phagocytosis and endocytic pathways, as well as pore formation (Figure) .
Phagocytosis
Phagocytosis of microbubbles is thought to act by classic phagocytic principles, with the tiny bubbles being ultimately encapsulated, along with any macromolecules in the extracellular milieu, in phagocytic vesicles. The precise mechanism of phagosome escape or microbubble/phagosome membrane interactions is unclear. Several studies have identified the phagocytosis of microbubbles by activated cells. 5, 6 One has shown a substantial effect of lipid composition on the ability of Kupffer cells to engulf microbubbles, 7 producing a phagocytosis rate ranging from 0% to 99%. The microbubbles used by Meijering et al were SonoVue (Bracco Diagnostics Inc, Princeton, NJ), which have a phagocytosis rate of only 7% in that earlier study. It seems that microbubbles with a more complex lipid shell composition, such as 1,2-distearoyl-glycero-3-phosphocholine, dipalmitoylphosphatidylglycerol, or dimyristoylphosphatidyl-choline, are less vulnerable to phagocytosis than simpler lipid compositions, such as palmitic acid, or other stabilizing molecules such as albumin. 7 Distinct cell types also have very different phagocytic capacities. Macrophages and neutrophils are the classic examples of phagocytic cells, but many cell types do exhibit phagocytosis of lipids, including endothelial cells. 8
Pore Formation and Endocytosis
The primary internalization mechanism attributed to both UTMD and low energy ultrasound processes has been transient pore formation, either by mechanical energy derived from implosion of the microbubbles, as with UTMD, or changes in cell permeability, perhaps attributable to microbubble oscillation very close to the cell membrane. 9 To date, there has been little examination of the various endocytic pathways (macropinocytosis or clathrin-or caveolinmediated) that may be involved in low energy ultrasound facilitation, 9, 10 and it has been widely expected that pore formation is the initiating event. 11, 12 However, few of these studies included any evaluation of endocytic mechanisms, and most were performed at acoustic pressures that would induce cavitation.
In this issue of Circulation Research, Meijering et al have examined the role of endocytic pathways when low acoustic pressure ultrasound is applied in conjunction with microbubbles to transfer macromolecules across the cell membrane. The authors use relatively specific pharmacological inhibitors of these pathways and ATP depletion to evaluate changes in the intensity of fluorescence from fluorescent The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association. moieties conjugated to dextran of various molecular weights. They find that inhibition of macropinocytosis or clathrin decreased absorbed fluorescence of all sizes of dextran particles, ranging from 4 to 500 kDa, and that inhibition of caveolin reduced only the particles with higher molecular mass. The authors also find positive correlation factors for immunohistological labeling of clathrin, and to a lesser extent caveolin, with dextran particles in both cultured endothelial cells and femoral artery endothelium exposed to low-power ultrasound and bubbles in vivo.
This evidence that ultrasound resonance in microbubbles can influence pathways of endocytosis is surprising, although there has been some independent support for an effect of ultrasound on caveolae. For example, Lionetti et al recently demonstrated the caveolin-mediated endocytosis of a GFP reporter protein following low-power sonography of human endothelial cells. 13 If endocytosis is involved and enhanced by microbubble oscillation, then a deeper mechanistic explanation will be required. Are these pathways in endothelial cells responding to vibrations of the microbubbles, either by direct contact or propagated fluid waves? Is the effect mediated by a biochemical response or a physiochemical alteration of the membrane lipids or proteins?
There are several potential limitations of the study. Damage to the integrity of the cells, from the experimental manipulations, the pharmacological inhibitors, or the ATP depletion, might lead to misinterpretation of nonspecific membrane leaks as active endocytic transport under these conditions of high exogenous concentrations of fluorescent molecules. Idiosyncratic subcellular localization of label, perhaps resulting from charge or hydrophobic characteristics of the indicator molecules, might resemble more specific subcellular localization. The quantitation of fluorescence, on which much of the study rests, is a fraught histological procedure, and it is difficult to control for all potential confounding effects.
Nonetheless, this study suggests an interesting and novel role for cellular processes in microbubble-augmented sonographic transport. It has been recognized that many sono-graphic and biochemical factors can affect the efficiency of this process. If the observations and hypothesis of this study are borne out in subsequent work, we will need to add the ultrasound stimulation of cellular endocytosis to our considerations for optimization of this promising technology.
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Figure.
Interaction of microbubbles with ultrasound at the endothelial surface. As microbubbles pass through the blood vessel, high-energy acoustic waves cavitate the bubbles, and the resulting energy drives fragments of the bubble into the surrounding tissue (A); or, as low-energy acoustic waves are applied, the surrounding cells take up macromolecules by various proposed mechanisms (B).
